Clinical Trial Update: A Phase 1 Study in Patients With HPV16+ Recurrent/ Metastatic Head and Neck Squamous Cell Carcinoma [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial conducted by Cue Biopharma in patients with HPV16-positive recurrent or metastatic head and neck squamous cell carcinoma has completed …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma
• Hpv-related Oropharyngeal Cancer
• Oropharyngeal Squamous Cell Carcinoma

Snippet

Sponsor: Cue Biopharma | Conditions: Head and Neck Cancer, HPV Positive Oropharyngeal Squamous Cell Carcinoma | Phase 1 | Status: COMPLETED